Scott Morgan

17PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersInstruments and techniquesCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 26, 2026
Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis.

|May 19, 2026
From Guidance to Practice: Understanding the 2026 AUA/ASTRO Clinically Localized Prostate Cancer Guideline Amendment.

|Mar 11, 2026
From STORM to steadier ground: refining radiotherapy for nodal oligorecurrent prostate cancer.

Anindita Das, Scott C Morgan

|Jan 13, 2026
Association Between Sociodemographic Marginalization and Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer: Population-Based Cohort Study in Ontario, Canada.

David-Dan Nguyen, Raj Satkunasivam, Khatereh Aminoltejari

|Dec 24, 2025
Canadian Prostate Cancer Trends in the Context of PSA Screening Guideline Changes.

Anna N Wilkinson, Larry F Ellison, Shary X Zhang

|Dec 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials.

Georges Gebrael, Neeraj Agarwal, Alicia K Morgans

Pageof 3

Frequent Collaborators

9 joint publications

Cristopher J D Wallis

8 joint publications

Soumyajit Roy

4 joint publications

Shawn Malone

3 joint publications

Daniel E Spratt